NCAPD2 is similarly upregulated in colorectal cancer and NCAPD2 inhibits autophagy and promotes CRC cell proliferation and migration through the Ca2+/CAMKK/AMPK/mTORC1 pathway and PARP-1/SIRT1 axis [27]. Here, PARP1 is linked to colorectal carcinoma.